The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis.

[1]  G. Stamp,et al.  Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel , 2004, Virchows Archiv.

[2]  E. Gabrielson,et al.  High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. M. Arias.  Epithelial Mesenchymal Interactions in Cancer and Development , 2001, Cell.

[4]  V. Kosma,et al.  Reduced expression of α-catenin, β-catenin, and γ-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer , 2001, Journal of clinical pathology.

[5]  H. S. Kim,et al.  Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. , 2001, The Journal of pathology.

[6]  A. Yamauchi,et al.  E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. , 2001, The Annals of thoracic surgery.

[7]  S. Hirohashi,et al.  Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. , 2001, Human pathology.

[8]  F. Fagotto,et al.  CRM1- and Ran-independent nuclear export of β-catenin , 2001, Current Biology.

[9]  E. Kumpulainen,et al.  Nuclear β catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma , 2001, Journal of clinical pathology.

[10]  W. Ho,et al.  A comparative study of the clinicopathological significance of E-cadherin and catenins (α, β, γ) expression in the surgical management of oral tongue carcinoma , 2001, Journal of Cancer Research and Clinical Oncology.

[11]  A. Gazdar,et al.  Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  K. Sugimachi,et al.  Expression of E-cadherin and β-catenin in human non-small cell lung cancer and the clinical significance , 2000 .

[13]  Y. Joo,et al.  Prognostic significance of E-cadherin/catenin complex expression in gastric cancer. , 2000, Journal of Korean medical science.

[14]  N. Kinukawa,et al.  Prognostic value of the preserved expression of the E‐cadherin and catenin families of adhesion molecules and of β‐catenin mutations in synovial sarcoma , 2000, The Journal of pathology.

[15]  P. Davaris,et al.  Prognostic value of E-cadherin, beta-catenin, P120ctn in patients with transitional cell bladder cancer. , 2000, Anticancer research.

[16]  Y. Maehara,et al.  Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer , 2000, British Journal of Cancer.

[17]  I. Jang,et al.  The role of E-cadherin expression in non-small cell lung cancer. , 2000, Journal of Korean medical science.

[18]  H Clevers,et al.  dTcf antagonises Wingless signalling during the development and patterning of the wing in Drosophila. , 2000, The International journal of developmental biology.

[19]  B. Henderson.  Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover , 2000, Nature Cell Biology.

[20]  Mariann Bienz,et al.  The APC tumour suppressor has a nuclear export function , 2000, Nature.

[21]  W. Dinjens,et al.  E‐cadherin—catenin cell—cell adhesion complex and human cancer , 2000, The British journal of surgery.

[22]  B. Gumbiner,et al.  A mode of regulation of beta-catenin signaling activity in Xenopus embryos independent of its levels. , 2000, Developmental biology.

[23]  C. Heizmann,et al.  Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. , 2000, International journal of oncology.

[24]  S. Lippman,et al.  Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas. , 2000, Anticancer research.

[25]  C. Bucana,et al.  Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  S. Lippman,et al.  Lung cancer chemoprevention. , 2000, Seminars in surgical oncology.

[27]  Joseph L Goldstein,et al.  Regulated Intramembrane Proteolysis A Control Mechanism Conserved from Bacteria to Humans , 2000, Cell.

[28]  S. Hellman,et al.  Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. , 2000, Cancer research.

[29]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[30]  H. Clevers,et al.  The Yin-Yang of TCF/beta-catenin signaling. , 2000, Advances in cancer research.

[31]  Taylor Murray,et al.  Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.

[32]  M. Pignatelli,et al.  Catenins and their associated proteins in colorectal cancer. , 2000, Histology and histopathology.

[33]  K. Koike,et al.  Prognostic value of nucleolar protein p120 in patients with resected lung adenocarcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Andreas Hecht,et al.  Functional Characterization of Multiple Transactivating Elements in β-Catenin, Some of Which Interact with the TATA-binding Proteinin Vitro * , 1999, The Journal of Biological Chemistry.

[35]  W. Smythe,et al.  Cadherin and catenin expression in normal human bronchial epithelium and non-small cell lung cancer. , 1999, Lung cancer.

[36]  Paul Polakis,et al.  The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors , 1999, Oncogene.

[37]  M. Takeichi,et al.  p120ctn Acts as an Inhibitory Regulator of Cadherin Function in Colon Carcinoma Cells , 1999, The Journal of cell biology.

[38]  Hideki Yamamoto,et al.  Phosphorylation of Axin, a Wnt Signal Negative Regulator, by Glycogen Synthase Kinase-3β Regulates Its Stability* , 1999, The Journal of Biological Chemistry.

[39]  M. Rifkin,et al.  The prognostic significance of proliferation‐associated nucleolar protein p120 expression in prostate adenocarcinoma , 1999, Cancer.

[40]  Frank McCormick,et al.  β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.

[41]  H. Terpe,et al.  CD44s, E-cadherin and PCNA as markers for progression in renal cell carcinoma. , 1999, Anticancer research.

[42]  W F Bodmer,et al.  Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Z. Kam,et al.  p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry , 1999, Oncogene.

[44]  P. Vogt,et al.  Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Retera,et al.  The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study. , 1998, Journal of clinical pathology.

[46]  H. Kato,et al.  Influence of E-cadherin dysfunction upon local invasion and metastasis in non-small cell lung cancer. , 1998, Lung cancer.

[47]  K. Syrigos,et al.  Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer. , 1998, Anticancer research.

[48]  M. Polette,et al.  Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas. , 1998, The American journal of pathology.

[49]  D. Rimm,et al.  Loss of p120ctn in human colorectal cancer predicts metastasis and poor survival. , 1998, Cancer letters.

[50]  E. Pennisi.  How a Growth Control Path Takes a Wrong Turn to Cancer , 1998, Science.

[51]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[52]  M. Bertagnolli,et al.  Aspirin prevents tumors in a murine model of familial adenomatous polyposis. , 1998, Surgery.

[53]  Robert S. Kerbel,et al.  E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1 , 1998, The Journal of cell biology.

[54]  A. Børresen-Dale,et al.  E‐cadherin and α‐, β‐, and γ‐catenin protein expression in relation to metastasis in human breast carcinoma , 1998 .

[55]  H. P. Wang,et al.  An immunohistochemical study of E-cadherin expression with correlations to clinicopathological features in gastric cancer. , 1998, Hepato-gastroenterology.

[56]  P. Matarrese,et al.  Antiproliferative activity of interferon α and retinoic acid in SiHa carcinoma cells: The role of cell adhesion , 1998, International journal of cancer.

[57]  Hideki Yamamoto,et al.  Axin, a Negative Regulator of the Wnt Signaling Pathway, Directly Interacts with Adenomatous Polyposis Coli and Regulates the Stabilization of β-Catenin* , 1998, The Journal of Biological Chemistry.

[58]  W. Birchmeier,et al.  Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. , 1998, Science.

[59]  J. Izbicki,et al.  Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  J. V. van Noord,et al.  Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer. , 1998, American journal of respiratory and critical care medicine.

[61]  P. Bonnier,et al.  Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival. , 1998, American journal of clinical pathology.

[62]  Gerhard Christofori,et al.  A causal role for E-cadherin in the transition from adenoma to carcinoma , 1998, Nature.

[63]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[64]  H Clevers,et al.  TCF/LEF factor earn their wings. , 1997, Trends in genetics : TIG.

[65]  N. Shepherd,et al.  Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. , 1997, Molecular pathology : MP.

[66]  S. Komiyama,et al.  All‐trans‐retinoic Acid‐dependent Inhibition of E‐Cadherin‐based Cell Adhesion with Concomitant Dephosphorylation of β‐Catenin in Metastatic Human Renal Carcinoma Cells , 1997, Japanese journal of cancer research : Gann.

[67]  A. Nagafuchi,et al.  Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. , 1997, Cancer research.

[68]  W. Hop,et al.  Reduced expression of the cadherin–catenin complex in oesophageal adenocarcinoma correlates with poor prognosis , 1997, The Journal of pathology.

[69]  B. van der Burg,et al.  Novel Progesterone Target Genes Identified by an Improved Differential Display Technique Suggest That Progestin-induced Growth Inhibition of Breast Cancer Cells Coincides with Enhancement of Differentiation* , 1997, The Journal of Biological Chemistry.

[70]  G Brabant,et al.  Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome. , 1997, Cancer research.

[71]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[72]  E. Surmacz,et al.  Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. , 1997, Experimental cell research.

[73]  J. Jankowski,et al.  Changes in gene structure and regulation of E-cadherin during epithelial development, differentiation, and disease. , 1997, Progress in nucleic acid research and molecular biology.

[74]  M. Monden,et al.  Decreased E‐cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus , 1996, The British journal of surgery.

[75]  B. Sanson,et al.  Uncoupling cadherin-based adhesion from wingless signalling in Drosophila , 1996, Nature.

[76]  C. Bierkamp,et al.  Cadherins and catenins in development. , 1996, Current opinion in cell biology.

[77]  J. Schalken,et al.  Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. , 1996, Cancer research.

[78]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[79]  W. Birchmeier,et al.  Prognostic value of E‐cadherin expression in 413 gastric carcinomas , 1996, International journal of cancer.

[80]  G. Berx,et al.  Cadherin/catenin complex: A target for antiinvasive therapy? , 1996, Journal of cellular biochemistry.

[81]  P. Polakis,et al.  Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes , 1996, Molecular and cellular biology.

[82]  M. Menger,et al.  Adhesion molecules as determinants of disease: From molecular biology to surgical research , 1996, The British journal of surgery.

[83]  M. Monden,et al.  E‐cadherin mediated adhesion system in cancer cells , 1996, Cancer.

[84]  B. Gumbiner,et al.  Binding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in Xenopus , 1996, The Journal of cell biology.

[85]  T. Tamaya,et al.  Progestins and danazol effect on cell-to-cell adhesion, and E-cadherin and α- and β-catenin mRNA expressions , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[86]  M. Mareel,et al.  Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid. , 1995, British Journal of Cancer.

[87]  G. Berx,et al.  Transition from the noninvasive to the invasive phenotype and loss of alpha-catenin in human colon cancer cells. , 1995, Cancer research.

[88]  W. Nelson,et al.  Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[89]  S. Byers,et al.  Role of E-cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: measurement of cell-cell adhesion strength. , 1995, Journal of cell science.

[90]  Peter D. Kwong,et al.  Structural basis of cell-cell adhesion by cadherins , 1995, Nature.

[91]  Y. Niitsu,et al.  Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39 , 1995, Molecular and cellular biology.

[92]  J. Fraumeni,et al.  Recent Cancer Trends in the United States , 1995 .

[93]  Y. Doki,et al.  Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line. , 1995, British Journal of Cancer.

[94]  S. Hirohashi,et al.  A Truncated β-Catenin Disrupts the Interaction between E-Cadherin and α-Catenin: A Cause of Loss of Intercellular Adhesiveness in Human Cancer Cell Lines , 1994 .

[95]  N. Lemoine,et al.  Loss of membranous E‐cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade, and advanced stage , 1994, The Journal of pathology.

[96]  J. Daniel,et al.  Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes , 1994, Molecular and cellular biology.

[97]  H. Aberle,et al.  Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor , 1994, The Journal of cell biology.

[98]  M. Mareel,et al.  Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. , 1994, Cancer research.

[99]  M. Pignatelli,et al.  Adhesion molecules: novel molecular tools in tumor pathology. , 1994, Human pathology.

[100]  R. Kemler,et al.  A short core region of E-cadherin is essential for catenin binding and is highly phosphorylated. , 1994, Cell adhesion and communication.

[101]  J. Taylor‐Papadimitriou,et al.  Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[102]  W. Birchmeier,et al.  Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. , 1994, Biochimica et biophysica acta.

[103]  S. Hirohashi,et al.  Frequent Loss of α Catenin Expression in Scirrhous Carcinomas with Scattered Cell Growth , 1994, Japanese journal of cancer research : Gann.

[104]  K. Nakagawa,et al.  Soluble E-cadherin fragments increased in circulation of cancer patients. , 1994, British Journal of Cancer.

[105]  J. Papkoff,et al.  Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing beta-catenin binding to the cell adhesion protein cadherin , 1994, The Journal of cell biology.

[106]  M. Takeichi,et al.  Relationship between e-cadherin expression and lymph-node metastasis in human esophageal cancer. , 1994, International journal of oncology.

[107]  A. Mercurio,et al.  Poorly differentiated colon carcinoma cell lines deficient in alpha-catenin expression express high levels of surface E-cadherin but lack Ca(2+)-dependent cell-cell adhesion. , 1993, Cell adhesion and communication.

[108]  W. Birchmeier,et al.  Deletion of the E‐cadherin gene in hepatitis B virus–positive chinese hepatocellular carcinomas , 1993, Hepatology.

[109]  M. Mareel,et al.  Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro. , 1993, British Journal of Cancer.

[110]  W. Isaacs,et al.  Reduction of E-Cadherin Levels and Deletion of the α-Catenin Gene in Human Prostate Cancer Cells , 1993 .

[111]  Y. Doki,et al.  Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line. , 1993, Cancer research.

[112]  M. Takeichi,et al.  Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. , 1993, Cancer research.

[113]  G. Klein,et al.  Decreased expression of E‐cadherin and increased invasive capacity in EBV‐LMP‐transfected human epithelial and murine adenocarcinoma cells , 1992, International journal of cancer.

[114]  S. Hirohashi,et al.  Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. , 1992, Cancer research.

[115]  G. Stamp,et al.  Relevance of risk assessment to exposed communities. , 1995, Environmental health perspectives.

[116]  W. Isaacs,et al.  Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. , 1992, Cancer research.

[117]  M J Wheelock,et al.  Plakoglobin, or an 83-kD homologue distinct from beta-catenin, interacts with E-cadherin and N-cadherin , 1992, The Journal of cell biology.

[118]  S. Hirohashi,et al.  Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organization , 1992, Cell.

[119]  R. Kemler,et al.  Molecular organization of the uvomorulin-catenin complex , 1992, The Journal of cell biology.

[120]  W. Birchmeier,et al.  The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[121]  C W Turck,et al.  A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. , 1991, Science.

[122]  F. Lottspeich,et al.  The uvomorulin-anchorage protein alpha catenin is a vinculin homologue. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[123]  M. Quintanilla,et al.  A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis , 1991, The Journal of cell biology.

[124]  L. Liotta,et al.  Tumor invasion and metastasis: an imbalance of positive and negative regulation. , 1991, Cancer research.

[125]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[126]  B. Obrink,et al.  Cell-cell contacts mediated by E-cadherin (uvomorulin) restrict invasive behavior of L-cells , 1991, The Journal of cell biology.

[127]  Y. Doki,et al.  Expression of immunoreactive E-cadherin adhesion molecules in human cancers. , 1991, The American journal of pathology.

[128]  M. Takeichi,et al.  The 102 kd cadherin-associated protein: Similarity to vinculin and posttranscriptional regulation of expression , 1991, Cell.

[129]  Y Shimoyama,et al.  Expression of E- and P-cadherin in gastric carcinomas. , 1991, Cancer research.

[130]  W. Birchmeier,et al.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells , 1991, The Journal of cell biology.

[131]  W. Fiers,et al.  Down‐regulation of E‐cadherin expression in madin darby canine kidney (MDCK) cells inside tumors of nude mice , 1991, International journal of cancer.

[132]  S. Hirohashi,et al.  Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[133]  W. Birchmeier,et al.  Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion , 1989, The Journal of cell biology.

[134]  M. Takeichi,et al.  Unstable Expression of E‐Cadherin Adhesion Molecules in Metastatic Ovarian Tumor Cells , 1989, Japanese journal of cancer research : Gann.

[135]  S. Hirohashi,et al.  Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. , 1989, Cancer research.

[136]  A. Mansouri,et al.  Regional assignment of the human loci for uvomorulin (UVO) and chymotrypsinogen B (CTRB) with the help of two overlapping deletions on the long arm of chromosome 16. , 1989, Cytogenetics and cell genetics.

[137]  M. Takeichi,et al.  Cell binding function of E‐cadherin is regulated by the cytoplasmic domain. , 1988, The EMBO journal.

[138]  K. Yasuda,et al.  Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA , 1987, Nature.

[139]  D. R. Coman.  Adhesiveness and stickiness: two independent properties of the cell surface. , 1961, Cancer research.